Motus GI Holdings Inc
OTC:MOTS
Motus GI Holdings Inc
OTC:MOTS
Price:
0.0001
USD
Market Closed
Market Cap:
$639
Relative Value
There is not enough data to reliably calculate the relative value of MOTS.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MOTS
Relative Value
Base Case
Not Available
Multiples Across Competitors
MOTS Competitors Multiples
Motus GI Holdings Inc Competitors
Motus GI Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Motus GI Holdings Inc
OTC:MOTS
|
223.9k USD | 0.8 | -0 | 0.4 | 0.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
202.2B USD | 4.6 | 31 | 17.5 | 23.9 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
179.8B USD | 17.9 | 63 | 47.9 | 58.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
147.8B USD | 5.9 | 45.5 | 23 | 27.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.6B USD | 3.5 | 27 | 14.6 | 21.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.3B USD | 5.6 | 38.7 | 23 | 30.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.7B EUR | 2.1 | 22.6 | 12.4 | 17.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.8B USD | 12.3 | 49.9 | 35.7 | 39.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.6B USD | 2.3 | 28.7 | 11 | 18.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.7B USD | 8.2 | 46.3 | 25.8 | 28.2 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.2B USD | 1.9 | 18.3 | 12.9 | 15.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
